INTRODUCTION {#s1}
============

Gastric cancer is the fourth most common form of cancer and the second most common cause of cancer-related deaths in the world, despite the declining incidence and mortality rates in recent decades \[[@R1]\]. The incidence of gastric cancer approximated 988,602 new cases and 723,000 deaths in 2013 worldwide \[[@R2]\]. Several environmental and lifestyle factors have already been established to play important roles in the etiology of gastric cancer \[[@R3]--[@R13]\]. Several meta-analyses have illustrated the effect of alcohol consumption on subsequent gastric cancer incidence and mortality \[[@R14], [@R15]\], however, whether these relationships differ according to different participant characteristics remains controversial.

The mechanism of the relationship between alcohol consumption and gastric cancer risk remains unclear. Recent evidence suggests that the high-density lipoprotein levels and anti-inflammatory effects associated with alcohol consumption might play an important role on the progression of gastric cancer \[[@R16]\]. Furthermore, the effect of alcohol abuse has already been established, with increased alcohol consumption associating with an increased risk of certain cancers. Previous studies have also evaluated the relationship between alcohol consumption and gastric cancer risk, yet these studies report inconclusive results \[[@R17]--[@R38]\]. Clarifying the optimal daily intake of alcohol is particularly important for the general population, as it has not been definitively determined. To obtain a more comprehensive understanding of the association between alcohol consumption and gastric cancer risk, we conducted a meta-analysis of prospective cohort studies to systematically evaluate the association between alcohol consumption and the risk of gastric cancer incidence or mortality and to compare these associations among participants with different baseline characteristics.

RESULTS {#s2}
=======

Literature search {#s2_1}
-----------------

The results of the study-selection process are shown in Figure [1](#F1){ref-type="fig"}. We identified 567 articles in our initial electronic search, of which 489 were excluded as duplicates and irrelevant studies, leaving a total of 78 potentially eligible studies for further evaluation. After detailed evaluations, 22 prospective cohort studies were selected for the final meta-analysis \[[@R17]--[@R38]\]. A manual search of the reference lists of these studies did not yield any new eligible studies. The general characteristics of the included studies are presented in Table [1](#T1){ref-type="table"}.

![Study selection process](oncotarget-08-84459-g001){#F1}

###### Baseline characteristics of studies included in the systematic review and meta-analysis

  Study                         Country       Sample size   Age at baseline   Gender (M/F)     GC incidence/ death cases   Follow-up (year)   Adjusted factors                                                                                                             NOS score
  ----------------------------- ------------- ------------- ----------------- ---------------- --------------------------- ------------------ ---------------------------------------------------------------------------------------------------------------------------- -----------
  Gordon 1984 \[[@R17]\]        US            5209          29--62            2106/2641        18                          22.0               Age, SBP, cigarettes/day, relative weight, and lipoproteins                                                                  7
  Kono 1987 \[[@R18]\]          Japan         5130          NA                5130/0           116                         19.0               Age, smoking                                                                                                                 6
  Stemmermann 1990 \[[@R19]\]   US            7572          ≥ 45              7572/0           174                         22.0               Age, smoking                                                                                                                 6
  Kato 1992 \[[@R20]\]          Japan         9753          ≥ 30              NA               57                          6.0                Sex, age, smoking, cooking methods, family history of stomach cancer                                                         7
  Galanis 1998 \[[@R21]\]       US            5546          ≥ 18              5546/0           64                          14.8               Age, education, place of birth, smoking                                                                                      7
  Fujino 2002 \[[@R22]\]        Japan         44930         ≥ 18              18746/26184      379                         7.3                Age                                                                                                                          8
  Sasazuki 2002 \[[@R23]\]      Japan         19657         40-59             19657/0          293                         10.0               Age, area, smoking, fruit, vegetable, salted cod roe or fish gut intake, BMI                                                 8
  Barstad 2005 \[[@R24]\]       Denmark       28463         21-93             15236/13227      122                         13.7               Sex, age, smoking                                                                                                            7
  Nakaya 2005 \[[@R25]\]        Japan         21201         40--64            21201/0          247                         7.2                Age, smoking, education, orange, other fruit juice, spinach, carrot or pumpkin and                                           7
  Study                         Country       Sample size   Age at baseline   Gender (M/F)     GC incidence/ death cases   Follow-up (year)   Adjusted factors                                                                                                             NOS score
                                                                                                                                              tomato consumption                                                                                                           
  Larsson 2006 \[[@R26]\]       Sweden        61433         40-76             0/61433          160                         15.7               Age, education, vegetable, fruit, processed meat and coffee intake, smoking                                                  8
  Sjodahl 2006 \[[@R27]\]       Norway        69962         ≥ 15              34202/35760      251                         16.0               Sex, age, BMI, education, smoking                                                                                            8
  Freedman 2007 \[[@R28]\]      US            474606        ≥ 50              282856/191750    472                         4.6                Sex, age, BMI, education, physical activity, vegetable, fruit and energy intake, smoking                                     8
  Sung 2007 \[[@R29]\]          Korea         669570        ≥ 30              669570/0         3452                        6.5                Age, BMI, smoking, preference for saltiness in food                                                                          7
  Kim 2010 \[[@R30]\]           Korea         2248129       30--80            1420981/827148   12393                       6.7                Age, sex, BMI, smoking habits, physical activity, and family history of cancer                                               7
  Steevens 2010 \[[@R31]\]      Netherlands   3962          55--70            1944/2018        655                         16.3               Sex, age, smoking, BMI, education, energy, fruit, vegetable and fish intake                                                  7
  Moy 2010 \[[@R32]\]           China         18244         45--64            18244/0          391                         20.0               Education, BMI, smoking, and summed intakes of preserved food items, fresh fruits, and fresh vegetables                      8
  Study                         Country       Sample size   Age at baseline   Gender (M/F)     GC incidence/ death cases   Follow-up (year)   Adjusted factors                                                                                                             NOS score
  Kim 2010 \[[@R33]\]           Korea         1341393       40--69            919199/422194    1326                        5.0                Age, residential, physical activity, BMI, SBP, DBP, and fasting blood sugar                                                  7
  Duell 2011 \[[@R34]\]         Europe        478459        35--70            142601/335858    444                         8.7                Age, sex, center, education, smoking, and intake of fruit/nuts/seeds, vegetables, processed and red meat, and total energy   8
  Everatt 2012 \[[@R35]\]       Lithuania     7150          40--59            7150/0           185                         30.0               Smoking, education level and BMI                                                                                             7
  Yang 2012 \[[@R36]\]          China         218189        40--79            218189/0         1137                        15.0               Age, area, smoking and education                                                                                             8
  Jung 2012 \[[@R37]\]          Korea         16320         ≥ 20              6405/9915        93                          9.3                Age, sex, BMI, smoking habit, geographic area, and educational attainment                                                    7
  Jayalekshmi 2015 \[[@R38]\]   India         65553         30--84            65553/0          116                         8.0                Age, calendar time, occupation, education, and smoking                                                                       7

\*GC: gastric cancer; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index.

Study characteristics {#s2_2}
---------------------

The twenty-two prospective cohort studies involved a total of 5,820,431 participants and data on 22,545 cases of gastric cancer morbidity or mortality. The follow-up period for participants was 4.6--30.0 years, while 3,962--2,248,129 individuals were included in each study. Four studies were conducted in the US \[[@R17], [@R19], [@R21], [@R28]\], 6 in Europe \[[@R24], [@R26], [@R27], [@R31], [@R34], [@R35]\], and the remaining 12 in Asia \[[@R18], [@R20], [@R22], [@R23], [@R25], [@R29], [@R30], [@R32], [@R33], [@R36]--[@R38]\]. Study quality was evaluated using the NOS. Overall, 8 studies had a score of 8 \[[@R22], [@R23], [@R26]--[@R28], [@R32], [@R34], [@R36]\], 12 studies had a score of 7 \[[@R17], [@R20], [@R21], [@R24], [@R25], [@R29]--[@R31], [@R33], [@R35], [@R37], [@R38]\], and the remaining 2 studies had a score of 6 \[[@R18], [@R19]\].

Drinking versus non-drinking for gastric cancer {#s2_3}
-----------------------------------------------

A total of 22 studies reported an association between alcohol consumption and the risk of gastric cancer. The summary RR showed that drinking participants in general were not associated with a greater risk of gastric cancer (RR: 1.03; 95% CI: 0.99--1.08; *P* = 0.176; Figure [2](#F2){ref-type="fig"}), with moderate heterogeneity detected (I^2^ = 21.9%; *P* = 0.162). A sensitivity analysis indicated that the conclusion was not changed after sequential exclusion of each individual study (Table [2](#T2){ref-type="table"}). Subgroup analysis indicated no significant associations between general alcohol consumption and the risk of gastric cancer in any specific subpopulations (Table [3](#T3){ref-type="table"}).

![Association between drinkers versus non-drinkers and the risk of gastric cancer](oncotarget-08-84459-g002){#F2}

###### Sensitivity analysis for drinkers vs non-drinkers

  Excluding study    RR and 95% CI       *P* value   Heterogeneity (%)   *P* value for heterogeneity
  ------------------ ------------------- ----------- ------------------- -----------------------------
  Gordon 1984        1.03 (0.98--1.08)   0.184       23.2                0.151
  Gordon 1984        1.03 (1.00--1.07)   0.088       4.2                 0.404
  Kono 1987          1.03 (0.98--1.08)   0.208       24.0                0.142
  Stemmermann 1990   1.03 (0.98--1.09)   0.217       24.7                0.134
  Kato 1992          1.03 (0.98--1.08)   0.202       16.6                0.233
  Galanis 1998       1.04 (0.99--1.08)   0.139       19.1                0.200
  Fujino 2002        1.03 (0.98--1.09)   0.183       25.2                0.129
  Fujino 2002        1.03 (0.98--1.08)   0.219       23.8                0.144
  Sasazuki 2002      1.04 (0.98--1.09)   0.173       25.0                0.131
  Barstad 2005       1.03 (0.98--1.08)   0.247       20.3                0.185
  Nakaya 2005        1.03 (0.98--1.09)   0.179       25.1                0.130
  Larsson 2006       1.03 (0.98--1.08)   0.212       22.2                0.163
  Sjodahl 2006       1.03 (0.98--1.08)   0.214       23.0                0.153
  Freedman 2007      1.04 (0.99--1.09)   0.084       15.3                0.249
  Sung 2007          1.03 (0.98--1.09)   0.294       23.1                0.152
  Kim 2010           1.04 (0.98--1.10)   0.210       24.5                0.136
  Steevens 2010      1.04 (0.99--1.09)   0.130       22.8                0.155
  Moy 2010           1.03 (0.98--1.09)   0.193       25.2                0.129
  Kim 2010           1.04 (0.98--1.10)   0.219       25.2                0.130
  Kim 2010           1.04 (0.99--1.09)   0.136       22.3                0.162
  Duell 2011         1.03 (0.98--1.09)   0.201       25.1                0.130
  Everatt 2012       1.03 (0.98--1.07)   0.232       15.2                0.251
  Yang 2012          1.04 (0.99--1.10)   0.122       22.6                0.157
  Jung 2012          1.03 (0.98--1.08)   0.197       24.7                0.134
  Jayalekshmi 2015   1.03 (0.98--1.08)   0.222       21.7                0.168

###### Subgroup analysis for drinkers versus non-drinkers and the risk of gastric cancer

  Group                             RR and 95% CI       *P* value   Heterogeneity (%)   *P* value for heterogeneity   Ratio between subgroups   *P* value for interaction test
  --------------------------------- ------------------- ----------- ------------------- ----------------------------- ------------------------- --------------------------------
  Country                                                                                                                                       
  US or Europe                      1.04 (0.89--1.21)   0.620       54.5                0.015                         1.01 (0.86--1.18)         0.904
  Asia                              1.03 (1.00--1.06)   0.090       0.0                 0.791                                                   
  Sample size                                                                                                                                   
  ≥ 10000                           1.03 (1.00--1.06)   0.098       0.0                 0.704                         0.97 (0.76--1.25)         0.821
  \< 10000                          1.06 (0.83--1.36)   0.658       61.2                0.012                                                   
  Gender                                                                                                                                        
  Men                               1.04 (0.97--1.12)   0.230       28.1                0.161                         1.03 (0.79--1.33)         0.825
  Women                             1.01 (0.79--1.30)   0.945       2.4                 0.380                                                   
  Outcomes                                                                                                                                      
  GC incidence                      1.05 (0.99--1.11)   0.135       24.5                0.177                         1.04 (0.92--1.17)         0.521
  GC mortality                      1.01 (0.91--1.12)   0t.919      24.6                0.225                                                   
  Adjusted BMI or not                                                                                                                           
  Yes                               1.02 (0.99--1.06)   0.152       1.2                 0.432                         0.94 (0.81--1.08)         0.358
  No                                1.09 (0.95--1.25)   0.206       37.5                0.083                                                   
  Adjusted educational attainment                                                                                                               
  Yes                               1.02 (0.93--1.12)   0.707       24.3                0.205                         0.98 (0.88--1.09)         0.722
  No                                1.04 (0.99--1.10)   0.127       23.8                0.203                                                   
  Adjusted physical activity                                                                                                                    
  Yes                               1.00 (0.95--1.07)   0.897       30.9                0.227                         0.93 (0.85--1.02)         0.151
  No                                1.07 (0.99--1.14)   0.072       19.6                0.206                                                   

Light alcohol consumption versus non-drinkers for gastric cancer {#s2_4}
----------------------------------------------------------------

A total of 12 studies reported an association between light alcohol consumption and the risk of gastric cancer. Pooled analysis results indicated that there was no association between alcohol consumption and gastric cancer (RR: 0.95; 95% CI: 0.88--1.02; *P* = 0.177; Figure [3](#F3){ref-type="fig"}). Furthermore, no significant heterogeneity was detected and the results of the sensitivity analysis indicated that the conclusion was not affected by the exclusion of any specific study ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Subgroup analysis indicated that light alcohol consumption was associated with lower risk of gastric cancer in women (RR: 0.74; 95% CI: 0.57--0.98; *P* = 0.035; Table [4](#T4){ref-type="table"}), whereas no other significant differences were detected.

![Association between light alcohol consumption and the risk of gastric cancer](oncotarget-08-84459-g003){#F3}

###### Subgroup analysis for light, moderate, and heavy drinking versus non-drinkers and the risk of gastric cancer

                Subgroup                       Light alcohol           *P* value   Moderate alcohol    *P* value   Heavy alcohol           *P* value
  ------------- ------------------------------ ----------------------- ----------- ------------------- ----------- ----------------------- --------------
  Country       US or Europe                   1.00 (0.87--1.15)       0.961       1.03 (0.87--1.22)   0.721       **1.20 (1.03--1.41)**   **0.021**
                Asia                           0.93 (0.85--1.02)       0.108       1.06 (0.97--1.15)   0.177       **1.12 (1.04--1.20)**   **0.002**
                US or Europe vs Asia           1.08 (0.91--1.27)       0.393       0.97 (0.80--1.17)   0.766       1.07 (0.90--1.27)       0.433
  Sample size   ≥ 10000                        0.95 (0.86--1.04)       0.270       1.07 (0.99--1.15)   0.101       **1.13 (1.06--1.21)**   **\< 0.001**
                \< 10000                       0.93 (0.79--1.10)       0.393       0.92 (0.61--1.39)   0.686       1.23 (0.89--1.70)       0.214
                ≥ 10000 vs \< 10000            1.02 (0.84--1.24)       0.827       1.16 (0.77--1.77)   0.479       0.92 (0.66--1.28)       0.615
  Gender        Men                            0.96 (0.90--1.03)       0.302       1.06 (0.97--1.14)   0.188       **1.13 (1.06--1.22)**   **0.001**
                Women                          **0.74 (0.57--0.98)**   0.035       1.30 (0.90--1.87)   0.156       1.33 (0.79--2.24)       0.285
                Men vs women                   1.30 (0.98--1.72)       0.068       0.82 (0.56--1.19)   0.285       0.85 (0.50--1.44)       0.544
  Reported      GC incidence                   0.98 (0.90--1.06)       0.551       1.08 (0.99--1.17)   0.102       **1.18 (1.08--1.29)**   **\< 0.001**
  outcomes      GC mortality                   0.87 (0.73--1.05)       0.141       1.01 (0.88--1.15)   0.942       1.07 (0.97--1.19)       0.170
                GC incidence vs GC mortality   1.13 (0.92--1.37)       0.242       1.07 (0.91--1.25)   0.405       1.10 (0.96--1.26)       0.157
  Adjusted      Yes                            0.95 (0.89--1.02)       0.173       1.07 (0.98--1.17)   0.119       **1.17 (1.08--1.26)**   **\< 0.001**
  BMI or not    No                             1.00 (0.80--1.26)       0.985       0.98 (0.83--1.15)   0.781       1.05 (0.93--1.19)       0.440
                Yes vs no                      0.95 (0.75--1.20)       0.672       1.09 (0.91--1.31)   0.353       1.11 (0.96--1.29)       0.145
  Adjusted      Yes                            0.91 (0.81--1.02)       0.106       1.02 (0.90--1.17)   0.722       1.10 (0.99--1.22)       0.070
  educational   No                             0.97 (0.84--1.10)       0.606       1.07 (0.98--1.18)   0.133       **1.16 (1.06--1.26)**   **0.001**
  attainment    Yes vs no                      0.94 (0.79--1.12)       0.480       0.95 (0.81--1.12)   0.559       0.95 (0.85--1.05)       0.327
  Adjusted      Yes                            0.83 (0.57--1.20)       0.317       1.04 (0.91--1.20)   0.558       1.13 (0.99--1.28)       0.070
  physical      No                             0.97 (0.90--1.04)       0.373       1.05 (0.97--1.15)   0.223       **1.14 (1.05--1.23)**   **0.001**
  activity      Yes vs no                      0.86 (0.59--1.25)       0.420       0.99 (0.84--1.17)   0.908       0.99 (0.85--1.15)       0.909

Moderate alcohol consumption versus non-drinking for gastric cancer {#s2_5}
-------------------------------------------------------------------

A total of 15 studies reported an association between moderate alcohol consumption and the risk of gastric cancer. There was no significant association between moderate alcohol consumption and the risk of gastric cancer (RR: 1.05; 95% CI: 0.98--1.13; *P* = 0.168; with no evidence of heterogeneity. Figure [4](#F4){ref-type="fig"}). A sensitivity analysis was conducted, and the conclusion was not affected by the exclusion of any specific study from the pooled analysis ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). Subgroup analyses suggested no significant associations between moderate alcohol consumption and the risk of gastric cancer with any specific participant characteristics (Table [4](#T4){ref-type="table"}).

![Association between moderate alcohol consumption and the risk of gastric cancer](oncotarget-08-84459-g004){#F4}

Heavy alcohol consumption versus non-drinking for gastric cancer {#s2_6}
----------------------------------------------------------------

A total of 15 studies reported an association between heavy alcohol consumption and the risk of gastric cancer. The pooled analysis results for gastric cancer indicated that the comparison of the heavy alcohol consumption versus non-drinking showed a harmful effect (RR: 1.13; 95% CI: 1.06--1.21; *P* \< 0.001; without evidence of heterogeneity; Figure [5](#F5){ref-type="fig"}). The sensitivity analysis was conducted, and the conclusions were not changed by the exclusion of any individual study ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). Subgroup analyses indicated that heavy alcohol consumption was associated with an increased risk of gastric cancer regardless of country (US or Europe: RR, 1.20; 95% CI, 1.03--1.41, *P* = 0.021; Asia: RR, 1.12; 95% CI, 1.04--1.20, *P* = 0.002), whether the sample size of the study was ≥ 10,000 (RR: 1.13; 95% CI: 1.06--1.21; *P* \< 0.001), whether participants were male (RR: 1.13; 95% CI: 1.06--1.22; *P* = 0.001), whether the study reported gastric cancer incidence (RR: 1.18; 95% CI: 1.08--1.29; *P* \< 0.001), whether the study adjusted for BMI (RR: 1.17; 95% CI: 1.08-1.26; *P* \< 0.001), whether the study adjusted for educational attainment (RR: 1.16; 95% CI: 1.06--1.26; *P* = 0.001), and whether the study adjusted for physical activity (RR: 1.14; 95% CI: 1.05--1.23; *P* = 0.001).

![Association between heavy alcohol consumption and the risk of gastric cancer](oncotarget-08-84459-g005){#F5}

Dose-response analysis {#s2_7}
----------------------

As shown by Figure [6](#F6){ref-type="fig"} the *P* value for nonlinearity (*P* = 0.308), we found there was no statistically significant of nonlinear relationships between alcohol consumption intake and the risk of gastric cancer. Further, we noted all range of alcohol consumption were not associated with the risk of gastric cancer.

![Dose-response relations between alcohol consumption and relative risks of gastric cancer](oncotarget-08-84459-g006){#F6}

Publication bias {#s2_8}
----------------

A review of the funnel plots could not rule out the potential for publication bias for drinkers versus non-drinkers and gastric cancer risk (Figure [7](#F7){ref-type="fig"}). Furthermore, the Egger and Begg test results showed no evidence of publication bias (*P* value for Egger: 0.539; *P* value for Begg: 0.441).
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DISCUSSION {#s3}
==========

In the present meta-analysis, we reviewed twenty-two prospective cohort studies regarding the association between alcohol consumption and the risk of gastric cancer in 5,820,431 participants and 22,545 cases of gastric cancer morbidity or mortality with specific focus on broad characteristics. The pooled results concluded that there is a significant association between heavy alcohol consumption and gastric cancer with an overall 1.13-fold (95% CI: 1.06--1.21) increased risk in comparison with non-drinkers. Furthermore, light alcohol consumption might play a protective effect against gastric cancer in women.

A previous meta-analysis suggested that current drinkers with heavy alcohol consumption were associated with a greater risk of gastric cancer than non-drinker and indicated that the pooled RR was higher for gastric non-cardia than for gastric cardia adenocarcinomas, although these relationships did not have a statistically significant association \[[@R14]\]. Other studies posit that participants who consumed heavy alcohol also had an association with poor nutrition, which might affect the incidence of gastric cancer \[[@R39], [@R40]\]. However, since these findings were based on 44 case control and 15 cohort studies, the summary results and the findings of the stratified analysis might be biased due to the traditional case control study format introducing potential uncontrollable biases. Another meta-analysis based on 10 case control studies suggested that moderate and heavy alcohol consumption was associated with an elevated risk of gastric cancer, yet most studies were not included and the results are unreliable \[[@R15]\]. We therefore conducted this comprehensive quantitative meta-analysis of prospective cohort studies to better evaluate any possible association between alcohol consumption and gastric cancer.

The individual findings of most of the included studies agreed with the summary result for drinking versus non-drinking and gastric cancer risk. All included studies reported that light or moderate alcohol consumption had no significant effect on gastric cancer. However, the study conducted by Everatt et al reported an inconsistent result. This prospective study included 7,150 individuals in Lithuania and found that participants who consumed \> 100 g/week ethanol had a 90% increased risk of gastric cancer versus 0.1--9.9 g ethanol/week \[[@R35]\]. A possible reason for this difference could be that this amount of alcohol intake was significantly higher than the cutoff for the heavy drinkers group used for this analysis, so this higher level could induce gastric cancer over the heavy alcohol consumption category reported here. Furthermore, the duration of the follow-up periods were greater than expected, allowing investigators to acquire a large number of gastric cancer cases and obtain narrow 95% CI, i.e., greater statistical significance.

The summary results suggested light and moderate alcohol consumption were not associated with the risk of gastric cancer, while several studies have reported inconsistent results. The study conducted by Kim et al suggested alcohol consumption play a positively association with the risk of gastric cancer mortality \[[@R33]\]. Further, increased alcohol consumption were associated with an increased risk of distal and total gastric cancer \[[@R29]\]. The possible reason for this could be ethanol involved in cancer development through acetaldehyde, which could enhanced pro-carcinogenic activity, modulation of cell regeneration, and nutritional deficiencies \[[@R33]\]. In addition, this analysis suggests that heavy alcohol consumption plays a harmful effect on gastric cancer. Although most included studies reported no association for this, two of included studies reported similar results: Sung et al indicated a positive relationship between alcohol consumption and distal or total gastric cancer risk \[[@R29]\], and Everatt et al demonstrated a positive link between alcohol consumption and gastric cancer incidence in the Lithuanian population \[[@R35]\]. A possible reason for this could be that a key metabolite acetaldehyde, which can have a local toxic effect and correlates with the incidence of gastric cancer \[[@R41]\]. The pathogenesis caused by ethanol on gastric mucosal damage was correlated with the balance of gastric mucosal defense and external invasion \[[@R28], [@R31], [@R42]\]. Finally, the amount of alcohol consumption was correlated to the role of aldehyde dehydrogenase and alcohol dehydrogenase polymorphisms, which have already been demonstrated to associate with the risk of head and neck, esophageal, and gastric cancers \[[@R43]--[@R45]\].

Subgroup analysis indicated that light alcohol consumption was associated with a reduction in gastric cancer in women. A possible reason for this relationship could entail how alcohol consumption might affect women who have received menopausal hormone therapy, which could reduce the risk of gastric cancer \[[@R46], [@R47]\]. In addition, heavy alcohol consumption was associated with a greater risk of gastric cancer in multiple subsets, which could be due to the stable relationship between heavy alcohol consumption and gastric cancer risk. These relationships in specific populations should be verified in further large-scale prospective cohort studies.

On dose-response meta-analysis, we found no nonlinear relationships between alcohol consumption and gastric cancer, and alcohol consumption has no significant effect on the risk of gastric cancer. The possible explanations for this could be that derive the dose-response curve required the distributions of cases and persons or person-years and effect estimate (RRs or HRs) with the variance estimates for at least 3 quantitative exposure categories, while these data were not available in several studies.

Four strengths of this meta-analysis should be highlighted, and are listed as follows: (1) our study was based on prospective cohort studies, which could eliminate selection and recall bias better than retrospective observational studies; (2) the alcohol consumption categories were divided into light, moderate, and heavy alcohol consumption, which could more accurately assess the dose relationship between alcohol consumption and gastric cancer; (3) a large number of participants was included, allowing us to quantitatively evaluate the association between alcohol consumption and the risk of gastric cancer morbidity and mortality, providing more robust findings for this study than those of any individual study; and (4) the RR were calculated in participants with specific characteristics to evaluate the difference in each subset for the relationship between alcohol consumption and the risk of gastric cancer.

The limitations of this study should also be acknowledged. First, the adjusted models are different across the included studies, and these factors might play an important role in the development of gastric cancer. Second, the range of alcohol consumption and cut-off values for consumption categories differed between studies, which might bias the observed effects of alcohol consumption. Third, *Helicobacter pylori* infection is a major risk factor for gastric cancer, but nearly all of the included studies were not adjusted for *H. pylori* status \[[@R48]\]. Fourth, the relationship between alcohol consumption and gastric cancer according to different histological type were not calculated due to smaller number of studies reported the effect estimate separately. Finally, this study was based on summary effect estimates, and individual data were not available, restricting us from conducting a more detailed relevant analysis.

The findings of this study suggest that, as compared with non-drinkers, drinking in general was not associated with the risk of gastric cancer. Light alcohol consumption might play an important role on gastric cancer in women, while no significant association was seen in other subsets. There was also no significant difference seen on gastric cancer risk for moderate alcohol consumption. Finally, heavy alcohol consumption significantly increased the risk of gastric cancer across all subgroups. Future studies should focus on specific population characteristics and different gastric cancer subtypes to further analyze this relationship.

MATERIALS AND METHODS {#s4}
=====================

Data sources, search strategy, and selection criteria {#s4_1}
-----------------------------------------------------

This study was conducted and reported following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines \[[@R49]\]. Three electronic databases (PubMed, Embase, and Cochrane Library) were searched from their dates of inception through April 2017 for prospective cohort studies published in English. The core search terms included ("alcohol" OR "ethanol" OR "alcoholic") AND ("gastric" OR "stomach") AND ("carcinoma" OR "cancer" OR "neoplasm" OR "adenocarcinoma") AND "cohort" and excluded medical subject headings. Furthermore, the reference lists of the potentially included studies were reviewed to identify additional relevant studies. If multiple published reports from the same study were available, we included only the one with the most detailed information for both exposure and outcome. The medical subject heading, methods, patient population, design, exposure, and reported outcome were used to identify relevant studies.

The literature search and study selection was undertaken independently by 2 authors using a standardized approach. Any inconsistencies between these 2 authors were settled by group discussion until a consensus was reached. Studies that met the following criteria were included: (1) prospective cohort study with adult participants (i.e., 18 years or older); (2) reported outcomes of gastric cancer incidence or gastric cancer mortality; (3) the exposure of interest was alcohol consumption; and (4) reported adjusted risk estimates for the association between alcohol consumption and gastric cancer risk, or reported data sufficient to calculate these. Studies were excluded if they met the following exclusion criteria: (1) the study had a cross-sectional, case-control, retrospective cohort, or clinical trial design; (2) the study did not report effect estimates and 95% confidence intervals (CIs); (4) the exposure of interest was not alcohol consumption; and (5) the incidence of gastric cancer or gastric cancer mortality was not reported.

Data collection and quality assessment {#s4_2}
--------------------------------------

Data were extracted independently by two authors and reviewed by a third author. The following data were extracted: first author\'s name, publication year, country, sample size, age at baseline, number of men and women, number of gastric cancer incidence/death cases, follow-up duration periods, adjusted factors, and study design factors. A predesigned Excel (Microsoft Corporation) file was used to extract relevant information.

The Newcastle-Ottawa Scale (NOS) was used to evaluate methodological quality, which is quite comprehensive and has been partially validated for evaluating the quality of observational studies in meta-analyses \[[@R50]\]. The NOS is based on the following 3 subscales: selection of the study group (zero to four stars), quality of the adjustment for confounders (zero to two stars) and assessment of outcome or exposure (zero to three stars). A "star system" (range, 0--9) has been developed for assessment, with a higher score representing better methodological quality.

Statistical analysis {#s4_3}
--------------------

We examined the relationship between alcohol consumption and risk of gastric cancer morbidity and mortality on the basis of the effect estimate (odds ratio \[OR\], relative risk \[RR\], or hazard ratio \[HR\]) and its 95% CI published in each study. A semi-parametric method was employed to evaluate the association between light (0--12 g per day), moderate (12--24 g per day), or heavy alcohol (≥ 24 g per day) consumption and the risk of gastric cancer morbidity and mortality. The value assigned to each alcohol consumption category was the mid-point for closed categories, and the median for open categories (assuming a normal distribution for alcohol consumption). Further, the alcohol consumption categories were consistent in men and women. In addition, the fixed effect model was employed to calculate the summary RRs and 95% confidence intervals (CIs) for each category of alcohol consumption if more than one median of alcohol consumption in each study was classified into light, moderate, and heavy alcohol consumption. We combined the relationship between the light, moderate, heavy alcohol consumption versus non-drinkers and the risk of gastric cancer morbidity and mortality by using the random-effects model \[[@R51], [@R52]\]. Further, the dose-response curve was derive based on restricted cubic splines with 3 knots at fixed percentiles of 10%, 50%, and 90% of the distribution \[[@R53], [@R54]\].

Heterogeneity between studies was investigated using the Q statistic, and we considered *P* values \< 0.10 as indicative of significant heterogeneity \[[@R55], [@R56]\]. The sensitivity analyses were conducted for each category versus non-drinkers by removing each individual study from the overall analysis \[[@R57]\]. Subgroup analyses were conducted based on country, sample size, gender, reported outcomes, adjusted body mass index (BMI) or not, adjusted educational attainment or not, and adjusted physical activity or not. The ratio of RRs and the corresponding 95% CIs were calculated based on RRs and 95% CIs in each subset according to country, sample size, gender, reported outcomes, adjusted BMIR or not, adjusted educational attainment or not, and adjusted physical activity or not \[[@R58]\]. The funnel plot for drinkers versus non-drinkers and the risk of gastric cancer was performed, and the Egger \[[@R59]\] and Begg tests \[[@R60]\] were used to evaluate publication bias. All reported *P* values are 2-sided, and *P* values \< 0.05 were considered statistically significant for all included studies. Statistical analyses were performed using STATA software (version 10.0; Stata Corporation, College Station, TX, USA).
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